Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814196) titled 'Efficacy, and Cost-effectiveness of an Online ACT Intervention for Disorders of Gut-Brain Interaction (iACTforDGBI)' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Örebro University, Sweden
Condition:
Disorders of Gut-brain Interaction
Distress, Psychological
Intervention:
Behavioral: iACTforDGBI intervention
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 15, 2026
Target Sample Size: 200
To know...